News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Haurwitz Rachel E.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Haurwitz Rachel E. (Director) has filed a Form 4 on Seer, Inc.|
Txns:
| Granted 23,443 shares
@ $0
Granted 34,735 options to buy
@ $4.33, valued at
$150.4k
|
|
| 06/09/2023 |
4
| Haurwitz Rachel E. (President and CEO) has filed a Form 4 on Caribou Biosciences, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.96, valued at
$29.6k
|
|
| 03/22/2023 |
4
| Haurwitz Rachel E. (President and CEO) has filed a Form 4 on Caribou Biosciences, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.96, valued at
$29.6k
|
|
| 02/23/2023 |
4
| Haurwitz Rachel E. (President and CEO) has filed a Form 4 on Caribou Biosciences, Inc.|
Txns:
| Granted 510,500 options to buy
@ $6.12, valued at
$3.1M
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/09/2022 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/27/2022 |
4
| Haurwitz Rachel E. (President and CEO) has filed a Form 4 on Caribou Biosciences, Inc.|
Txns:
| Exercised 10,000 shares
@ $2.96, valued at
$29.6k
Exercised 10,000 options to buy
@ $0 |
|
| 12/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2021 |
4
| Haurwitz Rachel E. (Director) has filed a Form 4 on Seer, Inc.|
Txns:
| Granted 30,000 options to buy
@ $35.25, valued at
$1.1M
|
|
| 11/12/2021 |
3
| Haurwitz Rachel E. (Director) has filed a Form 3 on Seer, Inc. |
| 07/22/2021 |
3
| Haurwitz Rachel E. (See Remarks) has filed a Form 3 on Caribou Biosciences, Inc. |
| 05/11/2016 |
4
| Haurwitz Rachel E. (10% Owner) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Converted 174,806 shares
@ $0
Converted 5,244,234 shares
@ $0
Converted 270,352 options to buy
@ $0
Converted 8,110,599 options to buy
@ $0 |
|
| 05/09/2016 |
4
| Haurwitz Rachel E. (10% Owner) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 23,529 options to buy
@ $18, valued at
$423.5k
|
|
| 05/05/2016 |
3
| Haurwitz Rachel E. (10% Owner) has filed a Form 3 on Intellia Therapeutics, Inc. |
|
|